
Solvay has reached an agreement to sell its peptide subsidiary Peptisyntha SA to the holding company behind contract manufacturing organisation …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

